help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Katano, H.
Right arrow Articles by Sata, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Katano, H.
Right arrow Articles by Sata, T.
(American Journal of Pathology. 1999;155:47-52.)
© 1999 American Society for Investigative Pathology


Short Communication

High Expression of HHV-8-Encoded ORF73 Protein in Spindle-Shaped Cells of Kaposi's Sarcoma

Harutaka Katano*, Yuko Sato*, Takeshi Kurata*, Shigeo Mori{dagger} and Tetsutaro Sata*{ddagger}

From the Department of Pathology*
and Laboratory of Pathology,{ddagger}
AIDS Research Center, National Institute of Infectious Diseases, and Department of Pathology,{dagger}
Institute of Medical Science, University of Tokyo, Tokyo, Japan

Human herpesvirus 8 (HHV-8) has been demonstrated previously in Kaposi's sarcoma (KS) tissues by immunohistochemistry, in situ polymerase chain reaction, and in situ hybridization. The HHV-8-encoded protein ORF73 is a 222- or 234-kd protein named latent nuclear antigen (LNA) or latency-associated nuclear antigen (LANA) that is identified in HHV-8-infected cell lines by immunofluorescence assay. In the present study, a rabbit antibody against a recombinant ORF73 protein was developed. Immunofluorescent staining of a HHV-8-infected cell line, TY-1, showed that the staining pattern of the anti-ORF73 antibody overlapped completely the LANA staining pattern obtained using KS patients' sera. Immunoblotting analysis showed that the anti-ORF73 antibody reacted specifically with 222- and 234-kd proteins that were present in TY-1 and BCBL-1 cell lysates. Immunohistochemistry using a catalyzed signal amplification system demonstrated that the anti-ORF73 antibody reacted exclusively with the majority of KS spindle-shaped cells, showing a nuclear dot-like staining pattern. Some of the ORF73 protein-positive cells also expressed CD34 and vimentin but not CD68 or factor-VIII-related antigen. These data indicate that the anti-ORF73 antibody recognizes LANA and that most KS cells are infected with HHV-8 in the latent phase. Our findings also suggest that ORF73 protein plays an important role in the pathogenesis of KS.





This article has been cited by other articles:


Home page
J. Virol.Home page
J. Liu, H. Martin, M. Shamay, C. Woodard, Q.-Q. Tang, and S. D. Hayward
Kaposi's Sarcoma-Associated Herpesvirus LANA Protein Downregulates Nuclear Glycogen Synthase Kinase 3 Activity and Consequently Blocks Differentiation
J. Virol., May 1, 2007; 81(9): 4722 - 4731.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Murakami, S. Yamagoe, K. Noguchi, Y. Takebe, N. Takahashi, Y. Uehara, and H. Fukazawa
Ets-1-dependent Expression of Vascular Endothelial Growth Factor Receptors Is Activated by Latency-associated Nuclear Antigen of Kaposi's Sarcoma-associated Herpesvirus through Interaction with Daxx
J. Biol. Chem., September 22, 2006; 281(38): 28113 - 28121.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Sakakibara, K. Ueda, K. Nishimura, E. Do, E. Ohsaki, T. Okuno, and K. Yamanishi
Accumulation of Heterochromatin Components on the Terminal Repeat Sequence of Kaposi's Sarcoma-Associated Herpesvirus Mediated by the Latency-Associated Nuclear Antigen
J. Virol., July 15, 2004; 78(14): 7299 - 7310.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
K Kamiyama, T Kinjo, K Chinen, T Iwamasa, H Uezato, J-i Miyagi, N Mori, and N Yamane
Human herpesvirus 8 (HHV8) sequence variations in HHV8 related tumours in Okinawa, a subtropical island in southern Japan
J. Clin. Pathol., May 1, 2004; 57(5): 529 - 535.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. C. Verma and E. S. Robertson
ORF73 of Herpesvirus Saimiri Strain C488 Tethers the Viral Genome to Metaphase Chromosomes and Binds to cis-Acting DNA Sequences in the Terminal Repeats
J. Virol., December 1, 2003; 77(23): 12494 - 12506.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S.-J. Gao, J.-H. Deng, and F.-C. Zhou
Productive Lytic Replication of a Recombinant Kaposi's Sarcoma-Associated Herpesvirus in Efficient Primary Infection of Primary Human Endothelial Cells
J. Virol., September 15, 2003; 77(18): 9738 - 9749.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Tomescu, W. K. Law, and D. H. Kedes
Surface Downregulation of Major Histocompatibility Complex Class I, PE-CAM, and ICAM-1 following De Novo Infection of Endothelial Cells with Kaposi's Sarcoma-Associated Herpesvirus
J. Virol., September 1, 2003; 77(17): 9669 - 9684.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Fujimuro and S. D. Hayward
The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Manipulates the Activity of Glycogen Synthase Kinase-3{beta}
J. Virol., July 15, 2003; 77(14): 8019 - 8030.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
B.-S. Lee, M. Connole, Z. Tang, N. L. Harris, and J. U. Jung
Structural Analysis of the Kaposi's Sarcoma-Associated Herpesvirus K1 Protein
J. Virol., July 15, 2003; 77(14): 8072 - 8086.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Watanabe, M. Sugaya, A. M. Atkins, E. A. Aquilino, A. Yang, D. L. Borris, J. Brady, and A. Blauvelt
Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Prolongs the Life Span of Primary Human Umbilical Vein Endothelial Cells
J. Virol., June 1, 2003; 77(11): 6188 - 6196.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F.-C. Zhou, Y.-J. Zhang, J.-H. Deng, X.-P. Wang, H.-Y. Pan, E. Hettler, and S.-J. Gao
Efficient Infection by a Recombinant Kaposi's Sarcoma-Associated Herpesvirus Cloned in a Bacterial Artificial Chromosome: Application for Genetic Analysis
J. Virol., May 13, 2002; 76(12): 6185 - 6196.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
L. J. Coulter and H. W. Reid
Isolation and expression of three open reading frames from ovine herpesvirus-2
J. Gen. Virol., March 1, 2002; 83(3): 533 - 543.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
K. Mattsson, C. Kiss, G. M. Platt, G. R. Simpson, E. Kashuba, G. Klein, T. F. Schulz, and L. Szekely
Latent nuclear antigen of Kaposi's sarcoma herpesvirus/human herpesvirus-8 induces and relocates RING3 to nuclear heterochromatin regions
J. Gen. Virol., January 1, 2002; 83(1): 179 - 188.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Sakurada, H. Katano, T. Sata, H. Ohkuni, T. Watanabe, and S. Mori
Effective Human Herpesvirus 8 Infection of Human Umbilical Vein Endothelial Cells by Cell-Mediated Transmission
J. Virol., August 15, 2001; 75(16): 7717 - 7722.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Rivas, A.-E. Thlick, C. Parravicini, P. S. Moore, and Y. Chang
Kaposi's Sarcoma-Associated Herpesvirus LANA2 Is a B-Cell-Specific Latent Viral Protein That Inhibits p53
J. Virol., January 1, 2001; 75(1): 429 - 438.
[Abstract] [Full Text]


Home page
J. Virol.Home page
D. R. Schwam, R. L. Luciano, S. S. Mahajan, L. Wong, and A. C. Wilson
Carboxy Terminus of Human Herpesvirus 8 Latency-Associated Nuclear Antigen Mediates Dimerization, Transcriptional Repression, and Targeting to Nuclear Bodies
J. Virol., September 15, 2000; 74(18): 8532 - 8540.
[Abstract] [Full Text]


Home page
J. Virol.Home page
H. Katano, T. Iwasaki, N. Baba, M. Terai, S. Mori, A. Iwamoto, T. Kurata, and T. Sata
Identification of Antigenic Proteins Encoded by Human Herpesvirus 8 and Seroprevalence in the General Population and among Patients with and without Kaposi's Sarcoma
J. Virol., April 15, 2000; 74(8): 3478 - 3485.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Society for Investigative Pathology.